Trials / Terminated
TerminatedNCT04937608
Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection on the Sperm Parameters of Infertile Men
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Fertilys · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
This study aims to better understand the effects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, virus that causes the coronavirus disease 2019 (COVID-19), on male fertility.
Detailed description
After being informed about the study and potential risks, all patients giving written informed consent will produce a sperm sample by masturbation. Patients will also complete a questionnaire relating to their state of health. Six month following the first sperm sample, patients will produce another sperm sample by masturbation. These sperm parameters will be compared with the ones from a sperm analysis performed less than 2 years before the SARS-CoV-2 infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Sperm analysis | Routine sperm analysis including analysis of sperm concentration, motility, vitality and morphology. Sperm DNA integrity will also be assessed. |
Timeline
- Start date
- 2021-08-13
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-06-24
- Last updated
- 2023-09-18
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04937608. Inclusion in this directory is not an endorsement.